Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 6, 2004, Pages 628-638

  Wang, Bing ^a   Nichol, Janet L ^a   Sullivan, John T ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMG 531; LIGAND; PLACEBO; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HUMAN; MALE; NONLINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SORE THROAT; THROMBOCYTE COUNT;

ADULT; BIOSENSING TECHNIQUES; CARRIER PROTEINS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LIGANDS; MALE; NEOPLASM PROTEINS; PLATELET AGGREGATION INHIBITORS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, FC; RECEPTORS, THROMBOPOIETIN;

EID: 10044296968     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.08.010     Document Type: Article

References (27)

1. N. Methia, F. Louache, W. Vainchenker, F. Wendling Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryopoiesis Blood 5 1993 1395 1401
2. T.D. Bartley, J. Bogenberger, P. Hunt, Y.S. Li, H.S. Lu, F. Martin Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl Cell 77 1994 1117 1124
3. F.J. Desauvage, P.E. Hass, S.D. Spencer, B.E. Malloy, A.L. Gurney, S.A. Spencer Stimulation of megakaryocytopoiesis by the c-Mpl ligand Nature 369 1994 533 538
4. S. Lok, K. Kaushansky, R.D. Holly, J.L. Kuijper, C.E. Lofton-Day, P.J. Oort Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo Nature 369 1994 565 568
5. T. Kato, K. Ogami, Y. Shimada, A. Iwamatsu, Y. Sohma, H. Akahori Purification and characterization of thrombopoietin J Biochem (Tokyo) 118 1995 229 236
6. D.J. Kuter, D.L. Beeler, R.D. Rosenberg The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production Proc Natl Acad Sci U S A 91 1994 11104 11108
7. N. Debili, F. Wendling, A. Katz, J. Guichard, J. Breton-Gorius, P. Hunt The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors Blood 86 1996 2516 2525
8. W.P. Sheridan, E. Choi, C.F. Toombs, J. Nichol, M. Fanucchi, R.L. Basser Biology of thrombopoiesis and the role of Mpl ligand in the production and function of platelets Platelets 8 1997 319 332
9. J.L. Nichol The Mpl ligand and platelet homeostasis Acta Paediatr Suppl 424 1998 7 15
10. S. Vadhan-Raj Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia Semin Hematol 37 Suppl 4 2000 28 34
11. S. Vadhan-Raj Recombinant human thrombopoietin in myelosuppressive chemotherapy Oncology 15 Suppl 8 2001 35 38
12. L.T. Goodnough, D.J. Kuter, J. McCullough, S.J. Slichter, J. DiPersio, J. Romo Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin Blood 98 2001 1346 1351
13. D.J. Kuter, L.T. Goodnough, J. Romo, J. DiPersio, R. Peterson, D. Tomita Thrombopoietin therapy increases platelet yields in healthy platelet donors Blood 98 2001 1339 1345
14. L. Rice, J.L. Nichol, R. McMillan, L.K. Roskos, M. Bacile Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy Am J Hematol 68 2001 210 214
15. D.J. Kuter, C.G. Begley Recombinant human thrombopoietin: basic biology and evaluation of clinical studies Blood 100 2002 3457 3469
16. J. Li, C. Yang, Y. Xia, A. Bertino, J. Glaspy, M. Roberts, D.J. Kuter Thrombocytopenia caused by the development of antibodies to thrombopoietin Blood 98 2001 3241 3248
17. R.L. Basser, E. O'Flaherty, M. Green, M. Edmonds, J. Nichol, D.M. Menchaca Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor Blood 99 2002 2599 2602
18. V.C. Broudy, N.L. Lin AMG 531 stimulates megakaryopoiesis in vitro by binding to Mpl Cytokine 25 2004 52 60
19. D. Tomita, M. Petrarca, T. Paine, K. Olson, L. Roskos, E. Cheung The effect of a single dose of pegylated human recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet counts: preliminary results [abstract] Transfusion 37 Suppl 9S 1997 2S
20. S. Vadhan-Raj, L.J. Murray, C. Bueso-Ramos, S. Patel, S.P. Reddy, W.K. Hoots Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer Ann Intern Med 126 1997 673 681
21. R.L. Basser, J.E. Rasko, K. Clarke, J. Cebon, M.D. Green, S. Hussein Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) administered to patients with advanced cancer Lancet 348 1996 1279 1281
22. X. Du, D.A. Williams Interleukin-11: review of molecular, cellular biology, and clinical use Blood 89 1997 3897 3908
23. Neumega (oprelvekin) [package insert]. Cambridge (MA): Genetics Institute Inc; 2002.
24. E.P. Cronkite, V.P. Bond, T.M. Fliedner, D.A. Paglia, E.R. Adamik Studies on the origin, production and destruction of platelets S.A. Johnson R.W. Monto J.W. Rebuck R.C. Horn Blood platelets 1961 Little, Brown Boston p. 595 609
25. D.A. Goodkin, L.F. Gimenez, S.E. Graber, J.C. Van Stone, J.C. Egrie, D.M. Okamoto Hematocrit stability following intravenous versus subcutaneous administration of epoetin alfa to dialysis patients: a post hoc analysis Clin Nephrol 51 1999 367 372
26. E.P. Paganini, J.W. Eschbach, J.M. Lazarus, J.C. Van Stone, L.F. Gimenez, S.E. Graber Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients Am J Kidney Dis 26 1995 331 334
27. B. Wang, T.M. Ludden, E.N. Cheung, G.G. Schwab, L.K. Roskos Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteers J Pharmacokinet Pharmacodyn 28 2001 321 342